Topline
A meta-analysis suggests that most antivirals, including oseltamivir and zanamivir, offer limited benefits for nonsevere influenza cases, while baloxavir shows potential for reducing symptom duration and hospitalization in high-risk patients.
Study Details
Influenza continues to pose significant health risks globally, particularly among high-risk p…
